Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Claire Fraser files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christopher A. Kuebler - $1.44M in WAT purchases and sales in the last 12 months
- Thomas E. Polen Jr. - $1.17M in BDX purchases and sales in the last 12 months
- Michael David Garrison - $661K in BDX purchases and sales in the last 12 months
- Roland Goette - $441K in BDX purchases and sales in the last 12 months
- Richard H. Fearon - $306K in WAT purchases and sales in the last 12 months
- Bertram L. Scott - $212K in BDX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Claire Fraser?
Claire Fraser is a corporate insider of Seres Therapeutics, Inc. (MCRB). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Claire Fraser last file a Form 4?
The most recent primary Form 4 on record is dated 10 July 2026, one of 5 filings going back to 2025.
Has Claire Fraser been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($338K) across all tracked filings.
